Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 19, 2026

Defense Stock Face-Off: Lockheed Martin vs. Howmet Aerospace -- Which Is the Better Buy Right Now?

View original at nasdaq.com
Defense Stock Face-Off: Lockheed Martin vs. Howmet Aerospace -- Which Is the Better Buy Right Now? Key Points Lockheed Martin and Howmet Aerospace benefit from increased defense spending…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Lockheed Martin is a better buy than Howmet Aerospace due to steady income production, huge backlog, and greater diversity

    60% confidence
  • The war in Iran will push Howmet's likely growth higher in 2026

    60% confidence
  • Lockheed Martin's position as lead contractor for F-35 and major missile programs ensures steady cash flow largely insulated from traditional economic recessions

    60% confidence
  • The Motley Fool Stock Advisor identified 10 best stocks for investors to buy now, and Lockheed Martin was not one of them

    60% confidence
  • Howmet Aerospace is trading at more than 54 times forward earnings estimates, more than twice Lockheed's forward P/E ratio of 20.6, meaning much of Howmet's growth is already priced in

    60% confidence

Data points we hold from this source

Lockheed Martin Corporation · forward pe ratio20.6 ratio
Lockheed Martin Corporation · backlog194 USD
Lockheed Martin Corporation · quarterly dividend3.45 USD
Lockheed Martin Corporation · eps21.49 USD
Lockheed Martin Corporation · consecutive dividend increases23 years
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Defense Stock Face-Off: Lockheed Martin vs. Howmet Aerospace -- Which Is the Better Buy Right Now? — Source | Via News | ViaNews Market